Clinical Trials in Ireland

• A phase 2, double-masked, randomized, multicenter, parallel group, placebo-controlled study to investigate the efficacy and safety of GAL-10… Recruiting
  2024-519128-26-00 Phase II Non-foveal geographic atrophy secondary to non-neovascular a… Galimedix Therapeutics Inc.
• A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-022) Recruiting
  2023-508015-23-00 Phase III Ovarian cancer recurrent Merck Sharp & Dohme LLC
• A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting
  2024-512733-32-00 Phase III Acute Myeloid Leukemia (AML) Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
• A clinical trial to learn about the effects of VHB937 in people with amyotrophic lateral sclerosis (ALS) Recruiting
  2024-512536-29-00 Phase II Amyotrophic Lateral Sclerosis (ALS) Novartis Pharma AG
• A study to assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia Recruiting
  2024-515451-38-00 Phase III Primary Immune thrombocytopenia (ITP) Argenx
• An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting
  2023-507853-13-00 Phase II Ulcerative Colitis Eli Lilly & Co.
• Phase 3 Study of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Recruiting
  2023-503188-40-00 Phase III Active Ulcerative Colitis or Crohn’s Disease Takeda Development Center Americas Inc.
• A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham… Recruiting
  2023-504655-27-00 Phase III Primary Indeterminate Lesions or Small Choroidal Melanoma Aura Biosciences Inc.
• A study comparing niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma Recruiting
  2024-513077-48-00 Phase III O6-methylguanine methyltransferase (MGMT) unmethylated gliob… Neurotrials LLC
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting
  2024-514135-17-00 Phase III Immunoglobulin A Nephropathy Alpine Immune Sciences Inc.
• A phase 3 multi-center trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroids in children (ag… Recruiting
  2023-503630-44-00 Phase II/III Treatment of moderate-to-severe Atopic dermatitis Leo Pharma A/S
• A preventive study of bleeding episodes for children with severe von Willebrand disease (VWD). Recruiting
  2023-509877-22-00 Phase III severe von Willebrand Disease Takeda Development Center Americas Inc.
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better than Anti-PD1 Alone in Adult Participants with Resectable Stage 3 or 4… Recruiting
  2022-502825-17-00 Phase II Melanoma Regeneron Pharmaceuticals Inc.
• Clinical trial of MDNA11 (investigational drug) administered alone or in combination with pembrolizumab (immune checkpoint inhibitor) in Pat… Recruiting
  2023-507536-21-00 Phase I (FiH) Advanced Solid Tumors Medicenna Therapeutics Inc.
• Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Recruiting
  2023-504231-41-01 Phase II/III Locally advanced or metastatic urothelial cancer Bicycletx Limited
• Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER). Recruiting
  2023-504751-28-00 Phase III Exudative age-related macular degeneration King's College Hospital NHS Foundation Trust; King's College London
• A Phase 2 Clinical Trial to Investigate Safety, Tolerability and Efficacy of TransCon CNP, Weekly Subcutaneous Injections, Compared with Pla… Recruiting
  2023-506091-27-00 Phase II Achondroplasia in Children and Adolescents Ascendis Pharma Growth Disorders A/S
• Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting
  2023-504918-29-00 Phase III Hormone receptor positive breast cancer Merck Sharp & Dohme LLC
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participant… Recruiting
  2023-505678-14-00 Phase II Ulcerative Colitis AbbVie Deutschland GmbH & Co. KG
• Disitamab Vedotin with Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Recruiting
  2022-501105-12-00 Phase III Urothelial Carcinoma Seagen Inc.
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting
  2023-503699-25-00 Phase III Progressive Pulmonary Fibrosis Bristol-Myers Squibb Services Unlimited Company
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting
  2023-503697-21-01 Phase III Idiopathic pulmonary fibrosis Bristol-Myers Squibb Services Unlimited Company
• Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting
  2022-501606-35-01 Phase III/IV Platinum-sensitive epithelial ovarian, fallopian tube, or pr… AbbVie Deutschland GmbH & Co. KG
• Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients Recruiting
  2022-501157-36-00 Phase IV Critically ill patients who are dependent on high level medi… Monash University

Showing 49–72 of 444 trials